Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
IKT
RCKT
Add up to 3 more stocks
IKT
Inhibikase Therapeutics, Inc.
-1.00%
$1.98-0.02Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$261.43M
52W Range
$1.33 - $2.61
RCKT
Rocket Pharmaceuticals, Inc.
-4.98%
$2.48-0.13Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$270.80M
52W Range
$2.46 - $5.45
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.71 | 0.73 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -39.5% | -4.7% |
| ROA | -37.1% | -4.1% |
| ROIC | -42.9% | -48.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 15.82 | 9.24 |
| Quick Ratio | 15.82 | 9.24 |
| Debt/Equity | 0.00 | 0.07 |
| Interest Coverage | N/A | -120.84 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.